Virtual Reality for OCD

(VR-TMS Trial)

Overseen By Mina Ansari

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Yale University

No Placebo Group

Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

This study will focus on the use of Virtual Reality (VR) technology in patients receiving treatment using Transcranial Magnetic Stimulation (TMS) for Obsessive-Compulsive Disorder (OCD)

Research Team

Sina Nikayin, MD

Principal Investigator

Assistant Professor, Departement of Psychiatry, Yale University

Eligibility Criteria

This trial is for adults with OCD who are deemed suitable for TMS treatment by a Yale psychiatrist. Participants must be willing to follow the study's procedures and requirements, understand English, and not have hearing or visual impairments that would affect VR use.

Inclusion Criteria

Ability and willingness, in the investigator's judgement, to comply with the study procedure and study requirements.

I have been approved for TMS by a Yale psychiatrist for my OCD.

I am 18 years old or older.

Exclusion Criteria

Difficulty in understanding spoken or written English

Hearing or visual impairment to the degree that would interfere with ability to see or hear VR content

Any implanted medical device, risk of interference with which by the VR device in the investigator's judgment can put patient at additional undue risk

Treatment Details

Interventions

• Virtual Reality (Behavioural Intervention)

Trial Overview The study examines how using Virtual Reality (VR) technology before Transcranial Magnetic Stimulation (TMS) can impact the treatment of Obsessive-Compulsive Disorder (OCD).

Participant Groups

Group I: Treatment Group Experimental Treatment 1 Intervention

This single arm will include all participants of the study, who will all receive the intervention

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials

1,963

Recruited

3,046,000+